Contents. Contents (13) 1 Production (23)

Similar documents
GMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel

GMP MANUAL Contents. 1 Pharmaceutical Quality System (PQS)

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

GMP On Site Series. GMP Essentials

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

LEGAL REQUIREMENTS FOR STABILITY

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

18.H Questionnaire for preparing GMP-inspections

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND

Library Guide: Active Pharmaceutical

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

HACCP audit checklist

Annex 4. Guidance on good manufacturing practices: inspection report. Background

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Annex 14 WHO guidelines for drafting a site master file 136

On-Site GMP Training GMP COMPLIANCE TECHNICAL

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I

HISTORY AND MILESTONES

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

Good Manufacturing Practices Guidance Document

COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION

Risk classification guide for drug good manufacturing practices observations GUI-0023

Quality Assessment & GMP Similarities & Differences

Table of Contents. Legal Notices... 61

Conducting Supplier Audits: Ensure Validation Compliance

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART II

Aseptic Process Validation

GMP Requirements Based On WHO Guidelines for Ayush Premium Mark

Good Manufacturing Practices (GMPs) for Infant Formula

GOVERNMENT NOTICE NO. published on THE TANZANIA FOOD, DRUGS AND COSMETICS ACT (CAP 219) REGULATIONS. (Made under section 122(1)(o))

SESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY

Self-Evaluation/Audit Checklist for Food Supplement Manufacturers

APIC GUIDE FOR AUDITING REGISTERED STARTING MATERIAL MANUFACTURERS Version February, 2018

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

PERFORMANCE QUALIFICATION PROTOCOL HVAC SYSTEM

American Association for Laboratory Accreditation

Questionnaire Layout:

Standard Answers to FAQs from Customer Questionnaires

GMPs: Distribution Centers

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

A.1 Contents file 4 to 5 A.1 (1)

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

EU and FDA GMP Regulations: Overview and Comparison

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)

Your partner in the pharmaceutical industry

COMMERCIAL PRODUCT STABILITY

API Stability Protocols and. Chris Byrne Tasmanian Alkaloids

Lifecycle Product Quality Risk Management

Annex 6. Good trade and distribution practices for pharmaceutical starting materials

TANZANIA FOOD AND DRUGS AUTHORITY

The IFSQN FSSC Implementation Package

MEASURE FOR MEASURE: QUALITY METRICS

At Your ServIce. Microbiology Services. The life science business of Merck operates as MilliporeSigma in the U.S. and Canada.

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

SFHPHARM18 - SQA Unit Code FA2L 04 Prepare aseptic products

Guidelines for Process Validation of Pharmaceutical Dosage Forms

Annex 4. Assessment tool based on the model quality assurance system for procurement agencies: aide memoire for inspection

THE BASIC PRINCIPLES OF HACCP

GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART 1

Qualified Persons in the Pharmaceutical Industry Study Guide

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

NAFDAC. paths2 GOOD PRACTICES FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

CALIBRATION AND QUALIFICATION OF EQUIPMENTS IN THE PHARMACEUTICAL INDUSTRY: EMPHASIS ON RADIOPHARMACEUTICALS PRODUCTION

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

Microbiological Consideration for Non-Sterile Pharmaceutical

GOOD TRADE AND DISTRIBUTION PRACTICES FOR PHARMACEUTICAL STARTING MATERIALS. REVISION

Journal home page: RESEARCH ARTICLE

Comparison of Guidelines of Indian GMP with WHO GMP

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

Environmental Monitoring of Aseptic Processing Areas - 1

ISO 22000:2005 Standard INTERNATIONAL STANDARDS REGISTRATIONS

The Cleaning Validation Process

Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES

For analytical laboratories. A primer Good laboratory practice and current good manufacturing practice

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Process Validation Guidelines. Report highlights 23 rd February 2018

The validation of biological Active Pharmaceutical

Process validation in medical devices

INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW

Regulatory Expectations, Standards & Guidelines

Heating, ventilation, and air system encompasses heating, ventilation, and air conditioning, which is integral component of

Validation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness

Annex Draft Annex

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

TECTURA LIFE SCIENCES HIGHLIGHTS

Review Validation of aseptic processes for pharmaceuticals

Transcription:

1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing (31) 1.B.1.1 Clothing material (34) 1.B.1.2 Design of the clothing (35) 1.B.1.3 Preparation/Cleaning (39) 1.B.1.4 Gowning procedure (40) 1.B.2 Code of Conduct (41) 1.B.2.1 Personal hygiene (41) 1.B.2.2 General requirements (42) 1.B.2.3 Special requirements for clean rooms (42) 1.B.2.4 Policies to be established (43) 1.B.3 Hand disinfection (44) 1.B.4 Health requirements (45) 1.B.5 Training (46) 1.C Production hygiene (47) 1.C.1 Sources of contamination (50) 1.C.1.1 Premises and facilities (50) 1.C.1.2 Starting materials (52) 1.C.1.3 Packaging materials (52) 1.C.1.4 Cleansing agents, disinfectants and aids (53) 1.C.1.5 Equipment and utensils (54) 1.C.1.6 Process gases (55) 1.C.1.7 Ambient air (55) 1.C.1.8 Processes (56) 1.C.2 Cleaning (56) 1.C.2.1 Cleaning procedure for equipment (57) 1.C.2.2 Cleaning procedure for rooms (57) 1.C.3 Disinfection (58) 1.C.3.1 General procedure (58) 1.D Sanitation programme (61) 1.D.1 Organisation of room cleaning (61) 1.D.1.1 Hygienic areas (61) (13)

1.D.1.2 General room cleaning (61) 1.D.1.3 Cleansing agents and disinfectants (62) 1.D.1.4 Cleaning process and aids (64) 1.D.2 Documentation (65) 1.E Environmental monitoring (67) 1.E.1 General (67) 1.E.2 Sampling plan (69) 1.E.3 Establishment of limits and frequencies (70) 1.E.3.1 European requirements (70) 1.E.3.2 US requirements (73) 1.E.3.3 ISO standards (74) 1.E.4 Methods (75) 1.E.4.1 Direct contact test (75) 1.E.4.2 Measurement of airborne microbes (75) 1.E.5 Investigation areas (77) 1.E.5.1 Surfaces (77) 1.E.5.2 Air (78) 1.E.5.3 Cleansing agents and disinfectants (80) 1.E.5.4 Personnel (81) 1.E.5.5 Utilities (82) 1.E.6 Evaluation (82) 1.E.6.1 Report (82) 1.E.6.2 Trend analyses (82) 1.E.6.3 Measures when limit is exceeded (83) 1.F GMP in the production process (85) 1.G Weigh-in (89) 1.G.1 Legal requirements (89) 1.G.2 Weigh-in principles (91) 1.G.2.1 Product-specific weigh-in (92) 1.G.2.2 Raw material-specific weigh-in (92) 1.G.2.3 Central/local weigh-in systems (93) 1.G.2.4 Manual weigh-in (93) 1.G.2.5 Automatic weigh-in (94) 1.G.3 Weigh-in procedure (95) 1.G.3.1 Allocation of raw materials (96) 1.G.3.2 Weigh-in (96) 1.G.3.3 Return (98) 1.G.3.4 Allocation for production (98) 1.G.3.5 Cleaning (98) 1.G.4 Documentation (99) 1.H Identification (101) 1.H.1 Handling of labels (101) 1.H.2 Labelling of starting materials (102) (14)

1.H.3 Labelling of equipment and containers (103) 1.H.3.1 General (103) 1.H.3.2 Rejection / Quarantine (104) 1.H.3.3 Cleaning status (105) 1.H.4 Labelling of rooms (107) 1.I In-process control (109) 1.I.1 Objectives (110) 1.I.1.1 Quality control (110) 1.I.1.2 Process control (110) 1.I.2 Organisation and responsibilities (111) 1.I.3 Carrying out (112) 1.I.3.1 Scope and kind of tests (112) 1.I.3.2 Location (115) 1.I.3.3 Sampling (115) 1.I.3.4 Testing (116) 1.I.4 Documentation and evaluation of data (116) 1.J Prevention of cross-contamination (119) 1.J.1 Causes of cross-contamination (119) 1.J.1.1 Rooms (120) 1.J.1.2 Equipment (120) 1.J.1.3 Processes (122) 1.J.1.4 Personnel (122) 1.J.2 Measures to prevent cross-contamination (123) 1.J.3 Manufacture of critical products (124) 1.K Deviations (127) 1.K.1 Definition (127) 1.K.2 Procedure (128) 1.K.3 Responsibilities (130) 1.K.4 Measures (130) 1.K.5 Failure investigation report (131) 1.K.6 Evaluation of measures (133) 1.K.7 SOP deviations (example) (135) 1.K.8 Check-list for deviation handling (140) 1.L Reworking (145) 1.L.1 Definitions (145) 1.L.1.1 Rework (145) 1.L.1.2 Reprocessing (145) 1.L.1.3 Recovery (145) 1.L.2 Procedure (146) 1.L.2.1 Reasons for rework / reprocessing (146) 1.L.2.2 Request for rework / reprocessing (146) 1.L.2.3 Risk assessment (146) 1.L.2.4 Responsibilities (147) (15)

1.L.2.5 Documentation requirements (147) 1.L.2.6 Regulatory submission requirements (148) 1.L.3 Rework / Reprocessing of rejected products (148) 1.L.4 Rework of returned products (152) 1.L.5 Rework of products that have not been rejected (152) 1.M Warehouse and logistics (155) 1.M.1 Regulatory requirements (155) 1.M.2 Stock management system (156) 1.M.3 Responsibilities (160) 1.M.4 Personnel (160) 1.M.5 Storage areas (161) 1.M.5.1 Size (161) 1.M.5.2 Illumination (161) 1.M.5.3 Incoming goods and dispatch (161) 1.M.5.4 Sampling (162) 1.M.5.5 Quarantine (163) 1.M.5.6 Special storage areas (166) 1.M.6 Storage conditions (167) 1.M.6.1 Temperature and humidity (167) 1.M.6.2 Monitoring (167) 1.M.6.3 Deviation handling (170) 1.M.7 Sanitation and pest control (170) 1.M.8 Material Flow (172) 1.M.8.1 Stock rotation (172) 1.M.8.2 Reconciliation (173) 1.M.8.3 Storage systems (173) 1.M.9 Process Flow (176) 1.M.9.1 Receipt (176) 1.M.9.2 Identification (179) 1.M.9.3 Dispatch and transport (181) 2 Packaging (183) 2.A Packaging material (185) 2.A.1 Responsibilities (186) 2.A.2 (186) 2.A.3 Materials (186) 2.A.4 Protection against counterfeit medicinal products (190) 2.A.5 Packaging material testing (191) 2.A.5.1 Control tests carried out at the supplier (191) 2.A.5.2 Examples (192) 2.A.5.3 Defect evaluation lists (193) 2.A.5.4 Storage (195) 2.A.5.5 Labelling (196) (16)

2.B Packaging process (199) 2.B.1 Allocation of packaging material (200) 2.B.2 Line clearance (201) 2.B.3 Labelling (204) 2.B.4 Control functions (204) 2.B.5 Release for production (206) 2.B.6 In-process controls (213) 2.B.6.1 Organisation (213) 2.B.6.2 Function inspections (216) 2.B.6.3 Checking (partially) packed goods (218) 2.B.7 Cleaning primary containers (219) 2.B.8 Labelling (219) 2.B.9 Variable data (220) 2.B.10 Imprints (221) 2.B.11 Reconciliation (222) 2.B.12 Safety features (224) 2.B.13 Completion of a packaging process (224) 2.C Qualification of a packaging line (225) 2.C.1 Master qualification plan (226) 2.C.2 Design qualification (DQ) (232) 2.C.2.1 Design qualification protocol (232) 2.C.2.2 Design qualification report (234) 2.C.3 Installation qualification (IQ) (248) 2.C.3.1 Installation qualification protocol (248) 2.C.3.2 Installation qualification report (253) 2.C.4 Operational qualification (OQ) (258) 2.C.4.1 Operational qualification protocol (258) 2.C.4.2 Operational qualification report (263) 2.C.5 Performance qualification (PQ) (270) 2.C.5.1 Performance qualification protocol (270) 2.C.5.2 Performance qualification report (273) 3 Laboratory and Analytical Controls (277) 3.A Sampling (281) 3.A.1 Requirements (282) 3.A.1.1 Personnel (282) 3.A.1.2 Equipment (282) 3.A.1.3 Containers (283) 3.A.1.4 Premises (283) 3.A.2 Sampling plan (instructions) (283) 3.A.3 Notes for the sampling process (288) 3.A.3.1 Containers and identification labeling (288) 3.A.3.2 Sampling report (288) 3.A.3.3 Reference samples (289) (17)

3.B Reagents (291) 3.B.1 Labeling (292) 3.B.2 Usage and stability (292) 3.B.3 Documentation (294) 3.C Standards and reference substances (297) 3.C.1 Definition of different standards and their areas of use (297) 3.C.2 Handling, storage and stability (301) 3.D Qualifying laboratory instruments (305) 3.D.1 Qualification protocols and reports (305) 3.D.1.1 Design qualification (DQ) (306) 3.D.1.2 Installation qualification (IQ) (308) 3.D.1.3 Operational qualification (OQ) (308) 3.D.1.4 Performance qualification (PQ) (308) 3.D.2 System suitability test (SST) (309) 3.E Calibration in the lab (311) 3.E.1 Definitions (311) 3.E.1.1 Persons (311) 3.E.1.2 Instruments (311) 3.E.1.3 Working (312) 3.E.1.4 Laboratory Equipment Inventory List (313) 3.E.2 Calibration instructions and record (314) 3.E.2.1 Test intervals, test points, test instructions (314) 3.E.3 Examples (315) 3.E.3.1 Balance (315) 3.E.3.2 Volume measuring instruments (317) 3.E.3.3 Photometer (319) 3.E.3.4 HPLC system (321) 3.E.4 Decision (330) 3.E.4.1 Requirements, tolerances, specifications (330) 3.E.4.2 Equipment release (330) 3.E.4.3 Out of calibration (330) 3.F Validation of analytical methods (331) 3.F.1 Principles (331) 3.F.2 Definitions of the parameters (333) 3.F.2.1 Precision (333) 3.F.2.2 Accuracy (333) 3.F.2.3 LOD = Limit of Detection (334) 3.F.2.4 LOQ = Limit of Quantitation (334) 3.F.2.5 Selectivity (335) 3.F.2.6 Linearity, Range (335) 3.F.2.7 Robustness (335) 3.F.3 Documentation (336) 3.F.4 Revalidation (336) (18)

3.G Stability testing (339) 3.G.1 ICH guidelines for stability tests (340) 3.G.2 Storage and storage conditions (342) 3.G.2.1 Standard storage conditions (342) 3.G.2.2 Packaging (345) 3.G.2.3 Sample quantities (346) 3.G.2.4 Stress test (346) 3.G.2.5 Freeze test (347) 3.G.2.6 Temperature cycling test (348) 3.G.2.7 Special storage conditions for drug products (348) 3.G.2.8 Labeling (350) 3.G.3 Analyses (351) 3.G.3.1 Test parameters (352) 3.G.3.2 Reference samples (353) 3.G.3.3 Consumption test (353) 3.G.3.4 Compatibility test for injection solutions for infusions (353) 3.G.3.5 Analysis of compatibility of rubber stoppers and plastic components (353) 3.G.3.6 Photostability (ICH Q1B) (354) 3.G.3.7 Microbiological analyses (356) 3.G.3.8 Analysis of standing times (357) 3.G.3.9 Analysis of transport conditions (357) 3.G.4 Reduction of the study design (358) 3.G.4.1 Bracketing (359) 3.G.4.2 Matrixing (359) 3.G.5 Stability testing in the marketing phase (362) 3.G.5.1 Follow-up stability testing (FuST) (362) 3.G.5.2 Stability commitment (SC) (363) 3.G.6 Defining the retest period for an active pharmaceutical ingredient and the shelf life for a drug product through evaluation of stability data (ICH Q1E) (375) 3.G.6.1 Data evaluation for the retest period for APIs and shelf life for drug products that are intended for storage at room temperature (375) 3.G.6.2 Data evaluation for retest period for APIs and shelf life for drug products intended for storage in refrigerator (2 8 C) (377) 3.G.6.3 Data evaluation for retest period for APIs and shelf life 3.G.7 for drug products for intended storage in a freezer ( 20 C) (378) Decision tree for data evaluation for retest period or for APIs or drug products (excluding frozen products) (378) 3.G.8 Procedure for statistical analysis (378) 3.G.9 Examples of the statistical evaluation of stability data (380) 3.G.9.1 Data analysis for a single batch (380) 3.G.9.2 Data analysis of one attribute in each batch for several batches of the same product (known as One-Factor, Full-Design Studies) (381) (19)

3.G.9.3 Data analysis of all attributes for several batches (Multi-Factor, Full-Design Studies) (382) 3.H Out-of-specification results (383) 3.H.1 Significance (383) 3.H.1.1 The BARR Laboratories case (383) 3.H.1.2 The consequences (385) 3.H.2 Definitions (386) 3.H.3 FDA OOS Guidance (386) 3.H.4 Example for handling of an OOS result (394) 3.H.5 Trend tracking (395) 3.I Raw data documentation (403) 3.I.1 Principles (403) 3.I.2 Single sheet documentation system (405) 3.I.2.1 Cover sheet (405) 3.I.2.2 Data sheet (405) 3.I.2.3 Index sheet (409) 3.J Batch release (411) 3.J.1 Certification by a Qualified Person and release in accordance with EC GMP Guidelines (414) 3.J.1.1 Regulations contained in Directive 2001/83/EC (414) 3.J.1.2 Objectives of appendix 16 (415) 3.J.1.3 Cases of application (416) 3.J.2 Responsibility for issuing the release (418) 3.J.3 Publication of release (419) 3.J.4 Release procedures in practice (420) 3.K Microbiological testing (423) 3.K.1 Total microbial count (424) 3.K.1.1 Determination of the total microbial count (432) 3.K.1.2 Product testing (438) 3.K.1.3 Culture media and culture media checks (440) 3.K.1.4 Incubation (443) 3.K.1.5 Evaluation (443) 3.K.1.6 Validation of the method (445) 3.K.2 Specified microorganisms (446) 3.K.2.1 Detection of specified microorganisms (452) 3.K.2.2 Detection method for the specified microorganisms (454) 3.K.2.3 Evaluation (463) 3.K.2.4 Culture media and culture media tests (464) 3.K.2.5 Suitability test of the method (validation of the methods) (469) 3.K.3 Testing frequencies (470) 3.K.3.1 Preparations (470) 3.K.3.2 Raw materials (471) 3.K.4 Miscellaneous tests (474) (20)

3.K.4.1 Monitoring of the hygiene status (474) 3.K.4.2 Aseptic working conditions (477) 4 Documentation (479) 4.A Official requirements (481) 4.A.1 GMP-requirements managed and reviewed according to German pharma business regulations (481) 4.A.2 Requirements of the EU GMP Guideline (484) 4.A.3 Requirements of the US GMP Regulations (488) 4.A.4 Formal requirements (493) 4.A.5 Management and revision documentation (497) 4.B GMP-conforming documentation (501) 4.B.1 Handwritten entries (501) 4.B.2 Archiving (502) 4.B.3 Master-SOP GMP-conforming documentation (503) 4.C Batch documentation (509) 4.C.1 Manufacturing instructions/record (511) 4.C.1.1 Manufacturing instructions (511) 4.C.1.2 Batch processing record (512) 4.C.1.3 Master of manufacturing instructions/batch processing record (514) 4.C.2 Packaging instruction and batch packaging record (534) 4.C.2.1 Packaging instruction (534) 4.C.2.2 Batch packaging record (535) 4.C.3 Electronic batch recording (536) 4.C.3.1 Strategic objectives of an Electronic Batch Recording System (EBRS) (537) 4.C.3.2 GMP aspects (537) 4.C.4 Testing procedures and test protocol (539) 4.C.4.1 Testing procedures (539) 4.C.4.2 Test protocol (541) 4.C.5 Batch record review (544) 4.C.5.1 Regulatory requirements (544) 4.C.5.2 Benefits of an independent batch record review (544) 4.C.5.3 Responsibility and competencies (545) 4.C.5.4 Scope of a batch record review (545) 4.C.5.5 Deviations, changes relevant to marketing authorization, recording errors (546) 4.D Standard operating procedures (SOPs) (549) 4.D.1 Compilation (550) 4.D.1.1 Design and format (552) 4.D.1.2 Identification (554) 4.D.2 Approval and implementation (555) 4.D.3 Training (555) 4.D.4 Usage (556) (21)

4.D.5 Review (557) 4.D.6 Changes (557) 4.D.7 Withdrawing an operating procedure (558) 4.D.8 Administration (558) 4.D.8.1 Status identification (558) 4.D.8.2 Distribution (558) 4.D.8.3 Integration (559) 4.D.8.4 Use of computerized systems (559) 4.D.9 Archiving (560) 4.D.10 Example of an SOP Compilation and administration of operating procedures (561) 4.E Site master file (577) 4.E.1 Introduction (577) 4.E.2 Design (577) 4.E.2.1 General information (578) 4.E.2.2 Personnel (579) 4.E.2.3 Premises and equipment (580) 4.E.2.4 Documentation (583) 4.E.2.5 Production (585) 4.E.2.6 Quality control (586) 4.E.2.7 Contract manufacturing and analysis (586) 4.E.2.8 Distribution, complaints and product recall (587) 4.E.2.9 Self-inspection (588) 4.E.2.10 Appendix (589) 4.F Annual product review / Product quality review (591) 4.F.1 Documents required for an annual product review (594) 4.F.2 Annual product review report (596) 4.F.3 Collaboration with a contract manufacturer (598) 4.F.4 Example: annual product review (599) 4.F.5 Master-SOP for the annual product review (604) Index (609) (22)